Live Markets

Loading markets...

Skin checks reveal a high percentage of 'harmless' melanomas

By Josh Piers - June 17, 2022 - 5 Mins Read

melanoma skin cancer

Josh Piers

Related posts

Breaking: GLP-1 Weight Loss and Exercise Decline in Users

Breaking: GLP-1 Weight Loss and Exercise Decline in Users

July 02, 2026

5-Minute Workday Hack to Beat Sitting Health Risks

5-Minute Workday Hack to Beat Sitting Health Risks

June 25, 2026

Strength Training Longevity: The 90-Minute Weekly Sweet Spot

Strength Training Longevity: The 90-Minute Weekly Sweet Spot

June 20, 2026

The Ozempic Workout Paradox: GLP-1 Weight Loss Exercise

The Ozempic Workout Paradox: GLP-1 Weight Loss Exercise

June 15, 2026

Recent Posts

Editors Picks

Breaking: Yale Aging Study Proves Mindset Matters for Healthy Aging

Breaking: Yale Aging Study Proves Mindset Matters for Healthy Aging

By Brennan Forrest - June 27, 2026 - 5 Mins Read

A groundbreaking 2026 Yale aging study reveals 45% of older adults improved cognitive and physical health through a positive longevity mindset.

Childhood Obesity Genetics: Parent-Child BMI Link Is Hereditary

Childhood Obesity Genetics: Parent-Child BMI Link Is Hereditary

By Dewey Olson - June 26, 2026 - 5 Mins Read

A groundbreaking PLOS Medicine study reveals the link between parent and child BMI is largely driven by genetics, not the prenatal environment.

5-Minute Workday Hack to Beat Sitting Health Risks

5-Minute Workday Hack to Beat Sitting Health Risks

By Brennan Forrest - June 25, 2026 - 5 Mins Read

A massive new study of over 19,000 adults reveals that taking a 5-minute walking break every hour is the ultimate way to combat prolonged sitting.

LSD Depression Clinical Trial: DT120 Pill Shines in Phase 3

LSD Depression Clinical Trial: DT120 Pill Shines in Phase 3

By Dewey Olson - June 24, 2026 - 5 Mins Read

Definium Therapeutics' LSD formulation DT120 delivered rapid, durable relief in a historic Phase 3 trial, redefining depression treatment.